152 related articles for article (PubMed ID: 28966242)
1. The Role of E-Cadherin/β-Catenin in Hydroxysafflor Yellow A Inhibiting Adhesion, Invasion, Migration and Lung Metastasis of Hepatoma Cells.
Ma L; Liu L; Ma Y; Xie H; Yu X; Wang X; Fan A; Ge D; Xu Y; Zhang Q; Song C
Biol Pharm Bull; 2017; 40(10):1706-1715. PubMed ID: 28966242
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
5. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A promotes osteogenesis and bone development via epigenetically regulating β-catenin and prevents ovariectomy-induced bone loss.
Wang P; Wang M; Zhuo T; Li Y; Lin W; Ding L; Zhang M; Zhou C; Zhang J; Li G; Wang H; Xu L
Int J Biochem Cell Biol; 2021 Aug; 137():106033. PubMed ID: 34216755
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Liu L; Si N; Ma Y; Ge D; Yu X; Fan A; Wang X; Hu J; Wei P; Ma L; Chen Z; Zhang Q; Feng C
Med Sci Monit; 2018 Feb; 24():803-811. PubMed ID: 29417935
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
Chen X; Wang Y; Zhang L; Gao Y
Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer.
Wu N; Li J; Luo H; Wang D; Bai X
Biomed Pharmacother; 2021 Apr; 136():111227. PubMed ID: 33485070
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
Song Y; Long L; Zhang N; Liu Y
Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
